Literature DB >> 24503913

The relationship between BNP, NTproBNP and echocardiographic measurements of systemic blood flow in very preterm infants.

K König1, K J Guy2, G Walsh2, S M Drew2, A Watkins2, C P Barfield2.   

Abstract

OBJECTIVE: Preterm infants are at risk of circulatory compromise following birth. Functional neonatal echocardiography including superior vena cava (SVC) flow is increasingly used in neonatal medicine, and low SVC flow has been associated with adverse outcome. However, echocardiography is not readily available in many neonatal units and B-type natriuretic peptides (BNPs) may be useful in guiding further cardiovascular assessment. This study investigated the relationship between BNP, N-terminal pro-BNP (NTproBNP) and echocardiographic measurements of systemic blood flow in very preterm infants. STUDY
DESIGN: This is a prospective observational study. Sixty preterm infants <32 weeks gestational age were included after the treating neonatologist had requested an echocardiogram for suspected cardiovascular compromise. BNP and NTproBNP were sampled just before the echocardiogram. Echocardiographic examination included fractional shortening (FS), SVC flow, left and right ventricular output (LVO and RVO). Statistical analysis included simple linear regression of BNP and NTproBNP with echocardiographic measures and multiple regression including potential confounding variables. RESULT: Mean (s.d.) gestational age at birth was 27(5) (2(1)) weeks, median (interquartile range, IQR) birth weight was 995 (845 to 1175) grams. Neither BNP nor NTproBNP correlated with SVC flow (BNP 95% confidence interval (CI) -0.0014 to 0.013, P=0.12; NTproBNP 95% CI -0.00069 to 0.01, P=0.085); LVO (BNP 95% CI -0.00078 to 0.0072, P=0.11; NTproBNP 95% CI -0.0034 to 0.0034, P=0.99); RVO (BNP 95% CI -0.00066 to 0.0058, P=0.12; NTproBNP 95% CI -0.0012 to 0.0044, P=0.25); or FS (BNP 95% CI -0.053 to 0.051, P=0.96; NTproBNP 95% CI -0.061 to 0.019, P=0.3). Multivariate linear regression did not significantly alter results.
CONCLUSION: In this cohort of very preterm infants, BNP and NTproBNP did not correlate with echocardiographic measurements of systemic blood flow within the first 72 h of life.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24503913     DOI: 10.1038/jp.2014.2

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  47 in total

1.  Superior vena cava flow in newborn infants: a novel marker of systemic blood flow.

Authors:  M Kluckow; N Evans
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

Review 2.  Point-of-care ultrasound in the neonatal intensive care unit: international perspectives.

Authors:  Nick Evans; Veronique Gournay; Fernando Cabanas; Martin Kluckow; Tina Leone; Alan Groves; Patrick McNamara; Luc Mertens
Journal:  Semin Fetal Neonatal Med       Date:  2011-02       Impact factor: 3.926

3.  Early determinants of right and left ventricular output in ventilated preterm infants.

Authors:  N Evans; M Kluckow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-03       Impact factor: 5.747

4.  The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates.

Authors:  Patrick A Flynn; Ralph L da Graca; Peter A M Auld; Mirjana Nesin; Charles S Kleinman
Journal:  J Pediatr       Date:  2005-07       Impact factor: 4.406

5.  N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants.

Authors:  Leon Joseph; Amiram Nir; Cathy Hammerman; Shmuel Goldberg; Efrat Ben Shalom; Elie Picard
Journal:  Am J Perinatol       Date:  2009-12-11       Impact factor: 1.862

Review 6.  Natriuretic peptides.

Authors:  Lori B Daniels; Alan S Maisel
Journal:  J Am Coll Cardiol       Date:  2007-12-18       Impact factor: 24.094

7.  Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery.

Authors:  Ryan Hutfless; Radmila Kazanegra; Michael Madani; Meenakshi Awasthi Bhalla; Alisi Tulua-Tata; Amelia Chen; Paul Clopton; Cherimarie James; Albert Chiu; Alan S Maisel
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

8.  B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.

Authors:  A Mark Richards; M Gary Nicholls; Eric A Espiner; John G Lainchbury; Richard W Troughton; John Elliott; Christopher Frampton; John Turner; Ian G Crozier; Timothy G Yandle
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

9.  Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants.

Authors:  V F Puddy; C Amirmansour; A F Williams; D R J Singer
Journal:  Clin Sci (Lond)       Date:  2002-07       Impact factor: 6.124

10.  NT-proBNP Levels Improve the Ability of Predicting a Hemodynamically Significant Patent Ductus Arteriosus in Very Low-Birth-Weight Infants.

Authors:  Sujatha Buddhe; Sarita Dhuper; Roger Kim; Laya Weichbrod; Eman Mahdi; Nishant Shah; Sashi Kona; Myron Sokal
Journal:  J Clin Neonatol       Date:  2012-04
View more
  3 in total

1.  Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.

Authors:  Sarah Louise Harris; Kiran More; Bronwyn Dixon; Richard Troughton; Chris Pemberton; John Horwood; Nicola Ellis; Nicola Austin
Journal:  Eur J Pediatr       Date:  2018-01-19       Impact factor: 3.183

2.  N-terminal pro-brain natriuretic peptide as a biomarker for differentiating cardiac and pulmonary disease in term neonates with respiratory distress.

Authors:  Azza Mohamed Ahmed; Nagwa Abd El-Ghffar Mohamed; Enas Mokhtar Abdelhamid; Randa Ibrahim Taha; Maha M A Abo-Hashish
Journal:  J Saudi Heart Assoc       Date:  2020-04-17

3.  NT-Pro-BNP and echocardiography for the early assessment of cardiovascular dysfunction in neonates with sepsis.

Authors:  Chunyan Yang; Jing Ma; Lei Guo; Baoyun Li; Lina Wang; Meixue Li; Ting Wang; Ping Xu; Cuifen Zhao
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.